DE10194786T1 - Zusammensetzungen zur Verstärkung der Immunantwort - Google Patents

Zusammensetzungen zur Verstärkung der Immunantwort

Info

Publication number
DE10194786T1
DE10194786T1 DE10194786T DE10194786T DE10194786T1 DE 10194786 T1 DE10194786 T1 DE 10194786T1 DE 10194786 T DE10194786 T DE 10194786T DE 10194786 T DE10194786 T DE 10194786T DE 10194786 T1 DE10194786 T1 DE 10194786T1
Authority
DE
Germany
Prior art keywords
immune response
response enhancement
enhancement compositions
compositions
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10194786T
Other languages
English (en)
Inventor
Susan S Percival
Robin J Henken
Cyr John St
Clarence A Johnson
Terri L Butler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Bioenergy Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc, Bioenergy Inc filed Critical University of Florida
Publication of DE10194786T1 publication Critical patent/DE10194786T1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
DE10194786T 2000-01-07 2001-01-08 Zusammensetzungen zur Verstärkung der Immunantwort Withdrawn DE10194786T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17505000P 2000-01-07 2000-01-07
PCT/US2001/000524 WO2001051062A1 (en) 2000-01-07 2001-01-08 Compositions for enhancing the immune response

Publications (1)

Publication Number Publication Date
DE10194786T1 true DE10194786T1 (de) 2003-10-02

Family

ID=22638638

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10194786T Withdrawn DE10194786T1 (de) 2000-01-07 2001-01-08 Zusammensetzungen zur Verstärkung der Immunantwort

Country Status (7)

Country Link
US (1) US6663859B2 (de)
EP (1) EP1282424A1 (de)
AU (1) AU2770601A (de)
CA (1) CA2397707A1 (de)
DE (1) DE10194786T1 (de)
GB (1) GB2364642B (de)
WO (1) WO2001051062A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
BRPI0506485A (pt) * 2004-01-14 2007-02-13 Bioenergy Inc método para reduzir o tempo de recuperação de um mamìfero submetido a uma anestesia geral, método para aumentar a recuperação de sepsia e uma composição adequada para administração intravenosa
ES2393786T3 (es) * 2004-04-29 2012-12-28 Ribocor, Inc. Método para mejorar la eficacia ventilatoria
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
US20060269616A1 (en) * 2005-05-26 2006-11-30 Suracell, Inc. Supplement composition and method of use for enhancement of DNA repair process
US8143235B2 (en) * 2005-12-16 2012-03-27 N.V. Nutricia Use of dietary fibres against muscle wasting
BRPI0806231A2 (pt) * 2007-01-23 2011-09-06 Bioenergy Inc método para utilização da d-ribose no tratamento de arritimias cardìacas
US20090197819A1 (en) * 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20080312169A1 (en) * 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
US20090232750A1 (en) * 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
US20100055206A1 (en) * 2008-04-02 2010-03-04 St Cyr John A Use of ribose in first response to acute myocardial infarction
ITBO20100734A1 (it) * 2010-12-14 2012-06-15 Eliseo Garuti Composizione per il trattamento e la prevenzione della degenerazione cellulare
WO2017136143A1 (en) 2016-02-01 2017-08-10 Ribocor, Inc. Use of ribose for treatment of subjects having congestive heart failure

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110560A1 (de) * 1981-03-18 1982-10-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"
US4923851A (en) * 1987-12-29 1990-05-08 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4871718A (en) 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US5231085A (en) * 1988-10-31 1993-07-27 Sandoz Ltd. Compositions and methods for the enhancement of host defense mechanisms
US5177065A (en) 1990-12-26 1993-01-05 Silvetti Sr Anthony N Monosaccharide containing wound healing preparation
CZ235798A3 (cs) * 1996-01-24 1999-03-17 Aliatros Medical, A. S. Prostředek pro léčení rakoviny a způsob jeho výroby
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6339716B1 (en) * 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6159943A (en) 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
GB2353217B (en) * 1999-10-27 2001-07-18 Bioenergy Inc Use of ribose to treat fibromyalgia

Also Published As

Publication number Publication date
CA2397707A1 (en) 2001-07-19
GB2364642A8 (en) 2002-03-13
US20020028196A1 (en) 2002-03-07
GB0123223D0 (en) 2001-11-21
EP1282424A1 (de) 2003-02-12
GB2364642A (en) 2002-02-06
US6663859B2 (en) 2003-12-16
WO2001051062A1 (en) 2001-07-19
GB2364642B (en) 2004-10-27
AU2770601A (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ATE303787T1 (de) Schergelzusammensetzungen
IS2932B (is) Fúlvestrant samsetning
DE60234212D1 (de) Farbeffekt zusammensetzungen
NO2012018I2 (no) Canakinumab eller direkte ekvivalenter derav
AR028197A1 (es) Composiciones antitranspirantes
ATE476975T1 (de) Abführende zusammensetzungen
NO20026175L (no) Vaksinesammensetning
DE60114714D1 (de) Silikon-Entschäumer-Zusammensetzung
ATE553775T1 (de) Impstoffzusammesetzung
IS6915A (is) Lyfjablanda
DE60137637D1 (de) Magnetorheologische fettzusammensetzung
PT1250321E (pt) Composicao de gliburida
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60134551D1 (de) Harzzusammensetzung
DE10196796T1 (de) Apatit-verstärkte Harz-Zusammensetzung
DE10194786T1 (de) Zusammensetzungen zur Verstärkung der Immunantwort
DE60139339D1 (de) Stabilisierte interferonzusammensetzungen
FI20000776A0 (fi) Elintarvikeseos
DE60116858D1 (de) Zusammensetzung
NO20013891D0 (no) Sammensetninger omfattende citalopram
DE60220392D1 (de) Schmierige silikonzusammensetzung
DE60119060D1 (de) Wasserabweisende Zusammensetzung
DE60115585D1 (de) Harzzusammensetzung
DE60122834D1 (de) Torsions-Kipp-Komponente

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law

Ref document number: 10194786

Country of ref document: DE

Date of ref document: 20031002

Kind code of ref document: P

8139 Disposal/non-payment of the annual fee